arrow
F

Florian P. Maurer

research center borstel
H指数:37
被引数:3,664

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Leptospirosis Prevalence and Risk Factors Among Patients Presenting With Fever to 4 Healthcare Sites in Sub-Saharan Africa and South East Asia: An International Multisite Observational and Nested Case-Control Study

莱姆病流行率及风险因素:来自撒哈拉以南非洲和东南亚4个医疗机构的发热患者国际多中心观察性及巢式病例对照研究

2025-10-010
OAAI
Impact of enhanced infection control and antimicrobial stewardship on infections by Clostridioides difficile, vancomycin-resistant enterococci, and third-generation cephalosporin-resistant Enterobacterales: A stepped-wedge cluster intervention study

增强感染控制和抗菌药物管理的措施对艰难梭菌(Clostridioides difficile)、万古霉素耐药肠球菌(vancomycin-resistant enterococci)和第三代头孢菌素耐药肠杆菌科细菌(Enterobacterales)感染的影响:一项阶梯式楔形集群干预研究

2025-08-230
PREAI
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland

在奥地利,德国和瑞士治疗MDR,pre-xdr,XDR和利福平耐药结核病或至少对利福平不耐受的情况

2024-05-291
OA
Towards clinical breakpoints for non-tuberculous mycobacteria-Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution
2023-06-0132
OA
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement

结核分枝杆菌分子耐药性检测的临床意义: 2023 TBnet/resist-tb共识声明

2023-04-0126
PRE
Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region Action is Needed by all Member States

所有成员国都需要世界卫生组织欧洲区域行动中对耐多药结核病的诊断能力

2022-11-016
OAAI
Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing (vol 14, 52, 2022)
2022-09-200
OAAI
Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients

从德国囊性纤维化患者中回收的脓肿分枝杆菌分离株的分子流行病学

2022-08-3114
OAAI